Dermatologic manifestations in pediatric patients with inflammatory bowel disease

Mohsen Afarideh1, Katherine Bartoletta2, Megha M Tollefson1,2

  • 1Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.

Pediatric Dermatology
|February 7, 2024
PubMed

Insights

Dermatologic conditions are common in children with inflammatory bowel disease (IBD), with infections being most frequent. Crohn's disease (CD) patients show more angular cheilitis and perianal issues, while severe IBD correlates with psoriasis and pyoderma gangrenosum.

Area of Science:

  • Pediatric Gastroenterology
  • Dermatology
  • Inflammatory Bowel Disease Research

Background:

  • Limited data exists on the prevalence and severity correlation of skin lesions in pediatric inflammatory bowel disease (IBD).
  • Previous studies focused primarily on adult IBD patients, leaving a knowledge gap in understanding pediatric IBD-associated dermatoses.
  • This study addresses the need for comprehensive data on skin manifestations in children with IBD.

Purpose of the Study:

  • To determine the prevalence of dermatologic manifestations in children with IBD.
  • To investigate the correlation between IBD severity and specific skin lesions in pediatric patients.
  • To compare the occurrence of skin conditions between Crohn's disease (CD) and ulcerative colitis (UC) in children.

Main Methods:

  • Retrospective chart review of 528 pediatric patients (≤18 years) diagnosed with IBD at Mayo Clinic between 1999 and 2017.
  • Statistical analysis using Chi-Square/Fischer's exact test (p≤0.05) to compare outcomes between CD and UC cohorts.
  • Inclusion criteria required patients to have at least one dermatologic diagnosis recorded.

Main Results:

  • Out of 425 IBD patients with dermatologic diagnoses, infections were most common (42.8%).
  • Acne (30.8%), eczema (15.8%), and perianal skin tags (14.6%) were prevalent non-infectious conditions.
  • Children with CD showed higher rates of angular cheilitis, keratosis pilaris (KP), and perianal complications (p<0.05).
  • Fungal skin infections were more common in UC patients (p=0.017).
  • Severe IBD correlated with increased prevalence of perianal fistula/abscess, psoriasis, and pyoderma gangrenosum (PG) (p<0.05).

Conclusions:

  • Dermatologic conditions, particularly infections, are highly prevalent in pediatric IBD.
  • Children with CD are more prone to angular cheilitis, KP, and perianal skin issues compared to UC patients.
  • Perianal disease, psoriasis, and PG are significantly associated with more severe pediatric IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166